The CYP152-family P450 enzyme CypC of Bacillus subtilis converts non-natural substrates in plasma-driven biocatalysis
Applied Microbiology and Biotechnology · 2025
DOI: 10.1007/s00253-025-13568-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2025. Verfasst von Tim Dirks und 7 weiteren Autor:innen. Beteiligte Einrichtung: Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Bacillus subtilis, Cytochrome P-450 Enzyme System, Bacterial Proteins, Plasma Gases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Ruhr-Universität Bochum.
Abstract (Originalsprache)
Plasma-driven biocatalysis utilizes in situ H 2 O 2 production by atmospheric pressure plasmas to drive H 2 O 2 -dependent enzymatic reactions. Having previously established plasma-driven biocatalysis using recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to produce ( R )-1-phenylethanol from ethylbenzene, we here employed CypC from Bacillus subtilis 168 (synonyms: YbdT, P450BSβ), an integral enzyme of surfactin and fengycin biosynthesis. CypC naturally hydroxylates medium and long-chain carboxylic acids. With short-chain carboxylic acids as decoy molecules, it also converts non-natural substrates such as ethylbenzene. We optimized production and heme loading of CypC and established guaiacol and ABTS-based reactions to assess compatibility of CypC with plasma-driven biocatalysis regarding temperature and H 2 O 2 operating windows. With heptanoic acid as the decoy molecule and H 2 O 2 from stock solution, guaiacol and ABTS conversion yielded 18.28 and 21.13 nmol product min −1 nmol −1 CypC , respectively. We then supplied H 2 O 2 using a capillary plasma jet operated with 1280 ppm H 2 O in helium to convert ethylbenzene with immobilized CypC in a rotating bed reactor (5 ml reaction volume). After 120 min run time, a turnover number (TON) of 18.82 mol ( R )-1-PhOl mol −1 CypC was reached, demonstrating that plasma-driven biocatalysis can be extended to H 2 O 2 -dependent enzymes beyond r Aae UPO to expand the product range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.
- Plasma Interface Physics, Faculty of Physics and Astronomy, Ruhr University Bochum, Bochum, Germany.
- Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. julia.bandow@rub.de.
Förderung
- Deutsche Forschungsgemeinschaft
- Ruhr-Universität Bochum
Zitieren
APA
Dirks, T., Klopsch, S., Stoesser, D., Trenkle, S. D., Yayci, A., Schüttler, S., Golda, J., & Bandow, J. E. (2025). The CYP152-family P450 enzyme CypC of Bacillus subtilis converts non-natural substrates in plasma-driven biocatalysis. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-025-13568-1
Vancouver
Dirks T, Klopsch S, Stoesser D, Trenkle SD, Yayci A, Schüttler S, et al. The CYP152-family P450 enzyme CypC of Bacillus subtilis converts non-natural substrates in plasma-driven biocatalysis. Applied Microbiology and Biotechnology. 2025. doi:10.1007/s00253-025-13568-1
BibTeX
@article{Dirks2025,
author = {Dirks, Tim and Klopsch, Sabrina and Stoesser, Davina and Trenkle, Sophie Desdemona and Yayci, Abdulkadir and Schüttler, Steffen and Golda, Judith and Bandow, Julia Elisabeth},
title = {The CYP152-family P450 enzyme CypC of Bacillus subtilis converts non-natural substrates in plasma-driven biocatalysis},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
doi = {10.1007/s00253-025-13568-1}
}
EUVIMED